Concepedia

Jason T. Henry

JT

Statistics

Publications

17

Citations

953

H-Index

15

Active since

1999

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

HealthONE

Sarah Cannon

Dana-Farber Cancer Institute

Minneapolis Heart Institute Foundation

Jason T. Henry is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1999–2024

17

Publications

17

Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge

Christine M. Parseghian, Jonathan M. Loree, Van K. Morris et al. · Annals of Oncology · 2018 · 240 citations · Full text

, , +17

MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with <i>MTAP</i> -Deleted Cancer

Lars D. Engstrom, Ruth Aranda, Laura Waters et al. · Cancer Discovery · 2023 · 194 citations · Full text

, , +10

Clinical Characteristics and Outcomes of STEMI Patients With Cardiogenic Shock and Cardiac Arrest

Mohamed Omer, Jeffrey Tyler, Timothy D. Henry et al. · JACC: Cardiovascular Interventions · 2020 · 84 citations

, , +17

Comprehensive Clinical and Molecular Characterization of <i>KRAS</i><sup>G12C</sup>-Mutant Colorectal Cancer

Jason T. Henry, Oluwadara Coker, Saikat Chowdhury et al. · JCO Precision Oncology · 2021 · 64 citations · Full text

, , +13

Impact of age on treatment and outcomes in ST-elevation myocardial infarction

Marc C. Newell, Jason T. Henry, Timothy D. Henry et al. · American Heart Journal · 2011 · 55 citations

, , +12

1–5 of 17